Ovid Therapeutics, Inc. (OVID)
1.57
-0.01
(-0.63%)
USD |
NASDAQ |
Dec 09, 16:00
1.59
+0.02
(+1.27%)
After-Hours: 20:00
Ovid Therapeutics Shareholders Equity (Quarterly): 44.70M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AnaptysBio, Inc. | -29.42M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| MannKind Corp. | -44.55M |
| Cassava Sciences, Inc. | 81.57M |
| Cidara Therapeutics, Inc. | 422.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.85M |
| Total Liabilities (Quarterly) | 19.15M |
| Debt to Equity Ratio | 0.3079 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 0.56% |